inside the quickly evolving area of cancer therapeutics, understanding the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is vital for developing powerful solutions. One of the more promising ways is the use of in vitro bystander impact assays, which Participate in a pivotal job in enhancing therapeutic efficacy. These assays, provided by